Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,475,397 papers from all fields of science
Search
Sign In
Create Free Account
bruceantin
Known as:
2H-3, 11c-(Epoxymethano)phenanthro[10,1-bc]pyran, Picras-3-en-21-oic Acid Derivative
, Picras-3-en-21-oic acid, 15-[(3, 4-dimethyl-1-oxo-2-pentenyl)oxy]-13,20-epoxy-3,11,12-trihydroxy-2, 16-dioxo-, methyl ester, [11.beta.,12.alpha.,15.beta.(E)]-
, [11Beta,12alpha,15beta(E)]-15-[(3,4-dimethyl-1-oxo-2-pentenyl)oxy]-13,20-epoxy-3,11,12-trihydroxy-2,16-dioxopicras-3-en-21-oic Acid Methyl Ester
Expand
A triterpene quassinoid antineoplastic antibiotic isolated from the plant Brucea antidysenterica. Bruceantin inhibits the peptidyl transferase…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Quassins
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2004
Highly Cited
2004
Multiple Myeloma Regression Mediated by Bruceantin
M. Cuendet
,
K. Christov
,
+5 authors
J. Pezzuto
Clinical Cancer Research
2004
Corpus ID: 8927654
Purpose: Bruceantin has been shown to induce cell differentiation in a number of leukemia and lymphoma cell lines. It also down…
Expand
2004
2004
A Phase II study of Bruceantin (NSC-165, 563) in advanced malignant melanoma
J. Arseneau
,
J. Wolter
,
M. Kuperminc
,
J. Ruckdeschel
Investigational new drugs
2004
Corpus ID: 10454964
SummaryThe Eastern Cooperative Oncology Group (ECOG) conducted a Phase II trial of Bruceantin in malignant melanoma. Twenty-two…
Expand
Highly Cited
1987
Highly Cited
1987
23S ribosomal RNA mutations in halobacteria conferring resistance to the anti-80S ribosome targeted antibiotic anisomycin.
H. Hummel
,
A. Böck
Nucleic Acids Research
1987
Corpus ID: 6269302
Halobacterium (H.) halobium and H. cutirubrum mutants resistant to the anti-80S ribosome targeted inhibitor anisomycin were…
Expand
Highly Cited
1986
Highly Cited
1986
In Vitro Amoebicidal Testing of Natural Products; Part I. Methodology
Alison T. Keene1
,
Ann Harris1
,
+5 authors
Sabiha Qazi3
Planta Medica
1986
Corpus ID: 43608934
in vitro Entamoeba histolytica Cinchona Brucea in vitro
1985
1985
Studies related to the Robinson transposition reaction
R. Pariza
,
P. Fuchs
1985
Corpus ID: 209647379
On etudie la formation et la reactivite de dichloro-1,4 butenes-2 thiosubstitues en -2 conduisant a un nouveau sel de bis…
Expand
Highly Cited
1983
Highly Cited
1983
Genetic, biochemical, and cross-resistance studies with mutants of Chinese hamster ovary cells resistant to the anticancer drugs, VM-26 and VP16-213.
R. Gupta
Cancer Research
1983
Corpus ID: 16683502
The effects of the anticancer drugs 4′-demethylepipodophyllotoxin thenylidene β-d-glucoside and 4′-demethylepipodophyllotoxin…
Expand
1982
1982
Phase II trial of bruceantin in metastatic breast carcinoma
C. Wiseman
,
H. Yap
,
A. Bedikian
,
G. Bodey
,
G. Blumenschein
American Journal of Clinical Oncology
1982
Corpus ID: 27632884
A PHASE II EVALUATION OF BRUCEANTIN was carried out in 15 patients with refractory metastatic breast cancer. All patients had…
Expand
1981
1981
Mechanism of eukaryotic protein synthesis inhibition by brusatol.
W. Willingham
,
E. A. Stafford
,
+4 authors
I. Hall
Biochimica et Biophysica Acta
1981
Corpus ID: 26559441
1981
1981
Antitumor agents XLII: Comparison of antileukemic activity of helenalin, brusatol, and bruceantin and their esters on different strains of P-388 lymphocytic leukemic cells.
I. Hall
,
K. Lee
,
+4 authors
Y. Imakura
Journal of Pharmacy and Science
1981
Corpus ID: 25313604
Based on the fact that some known antineoplastic agents possess an ester moiety within their structure, the esters of helenalin…
Expand
1978
1978
In vivo characteristics of resistance and cross-resistance of an adriamycin-resistant subline of P388 leukemia.
R. Johnson
,
M. Chitnis
,
W. M. Embrey
,
E. Gregory
Cancer treatment reports
1978
Corpus ID: 24277260
A subline of P388 leukemia resistant to adriamycin (P388/ADR) was developed by exposure to the drug in vivo. Resistance to…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE